DK0949258T3 - Alfa-liponsyre i krystallinsk form - Google Patents

Alfa-liponsyre i krystallinsk form

Info

Publication number
DK0949258T3
DK0949258T3 DK99104155T DK99104155T DK0949258T3 DK 0949258 T3 DK0949258 T3 DK 0949258T3 DK 99104155 T DK99104155 T DK 99104155T DK 99104155 T DK99104155 T DK 99104155T DK 0949258 T3 DK0949258 T3 DK 0949258T3
Authority
DK
Denmark
Prior art keywords
alpha
crystalline form
lipoic acid
enantiomer
theta
Prior art date
Application number
DK99104155T
Other languages
English (en)
Inventor
Thomas Dr Beisswenger
Eberhard Oestreich
Karl-Friedrich Dr Landgraf
Gunter Dr Laban
Matthias Dr Rischer
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0949258T3 publication Critical patent/DK0949258T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Seasonings (AREA)
DK99104155T 1998-03-11 1999-03-02 Alfa-liponsyre i krystallinsk form DK0949258T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19810336A DE19810336A1 (de) 1998-03-11 1998-03-11 Alpha-Liponsäure mit neuartiger Modifikation
US09/074,645 US5994393A (en) 1998-03-11 1998-05-08 Alpha-lipoic acid with novel modification

Publications (1)

Publication Number Publication Date
DK0949258T3 true DK0949258T3 (da) 2002-01-28

Family

ID=26044524

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99104155T DK0949258T3 (da) 1998-03-11 1999-03-02 Alfa-liponsyre i krystallinsk form

Country Status (10)

Country Link
US (1) US5994393A (da)
EP (1) EP0949258B1 (da)
AT (1) ATE207914T1 (da)
CA (1) CA2265276C (da)
CY (1) CY1106435T1 (da)
DE (2) DE19810336A1 (da)
DK (1) DK0949258T3 (da)
ES (1) ES2164474T3 (da)
IN (1) IN186598B (da)
PT (1) PT949258E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834608A1 (de) * 1998-07-31 2000-02-03 Basf Ag Kristallmodifikation der Liponsäure
WO2001093824A1 (en) * 2000-06-06 2001-12-13 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
DE10151764A1 (de) * 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
EP1817058B1 (en) * 2004-11-24 2015-09-02 Hill's Pet Nutrition, Inc. Composition for use in improving liver clearance of xenobiotic substances in an animal
AU2005322887B2 (en) 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP2012510511A (ja) * 2008-12-01 2012-05-10 インヴアスク セラピューテイックス インコーポレイテッド レニン−アンジオテンシン−アルドステロン系阻害剤及びリポ酸化合物を含有する組成物、並びに、レニン−アンジオテンシン−アルドステロン系に関連した疾患の治療のためのそれらの使用
CN108484570B (zh) * 2018-05-15 2021-05-04 苏州富士莱医药股份有限公司 一种制备硫辛酸颗粒的方法及设备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95826B (pt) * 1989-11-09 1997-11-28 Asta Medica Ag Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE4235912C2 (de) * 1992-10-23 2002-12-05 Viatris Gmbh Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit

Also Published As

Publication number Publication date
CA2265276A1 (en) 1999-09-11
DE19810336A1 (de) 1999-09-23
IN186598B (da) 2001-10-06
ES2164474T3 (es) 2002-02-16
US5994393A (en) 1999-11-30
CY1106435T1 (el) 2011-04-06
DE59900364D1 (de) 2001-12-06
CA2265276C (en) 2009-09-08
ATE207914T1 (de) 2001-11-15
EP0949258B1 (de) 2001-10-31
PT949258E (pt) 2002-04-29
EP0949258A1 (de) 1999-10-13

Similar Documents

Publication Publication Date Title
GR3033191T3 (en) Dosage form comprising alpha-lipoic acid or solid salts thereof with improved bioavailability
EP1408084A3 (en) Epoxy resin compositions for the manufacture of void-free laminates
AU5267286A (en) Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicycloalkanes
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
WO2003051846A3 (de) Substituierte phenylderivate
WO1999030548A3 (en) Method for the preparation of citalopram
BG105515A (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
JPS52116465A (en) Peptides
WO2004028482A3 (en) Packaged personal care compositions
EP0031567A3 (en) Tetrapeptidesemicarbazide derivatives and their production and use
DK0949258T3 (da) Alfa-liponsyre i krystallinsk form
HU9602229D0 (en) Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
IL140826A0 (en) Crystal modification of lipoic acid
CA2333008A1 (en) New heterocyclically substituted amides, their production and their use
WO2001014493A3 (de) Anorganische beschichtungszusammensetzung, ein verfahren zu deren herstellung sowie deren verwendung
ZA845833B (en) Anti-viral compositions
EP0165458A3 (en) (+)-ambrox, process for production thereof and use thereof
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
ZA200207675B (en) Novel crystal form of pyrrolidylthiocarbapenem derivative.
IE42628L (en) 1,3,4-oxadiazoline derivatives
AU662409B2 (en) A method for preparing low free formaldehyde methylolhydantoins and compositions thereof
BR0107743A (pt) Liga para grade positiva fina para baterias de chumbo ácidas e processo para manufatura da grade
ATE464043T1 (de) Pharmazeutische zusammensetzung enthaltend l- arginin
IE45109L (en) N-2-imidazolidinylidene-benzeneamine
AU4695401A (en) Flavouring a foodstuff by incorporating an effective amount of at least one compound of the formula r1-s-r2 in which r1 and r2 represent a specific atom or group